Mir-25 is a potential treatment target for myocardial ischemic-reperfusion injury
J Chin Med Assoc
.
2020 May;83(5):419-420.
doi: 10.1097/JCMA.0000000000000295.
Authors
Shang-Feng Yang
1
2
,
Po-Hsun Huang
3
4
2
5
Affiliations
1
Division of Nephrology, Department of Medicine, Cheng Hsin General Hospital, Taipei, Taiwan, ROC.
2
Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
3
Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
4
Department of Critical Care Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
5
Cardiovascular Research Center, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
PMID:
32168076
DOI:
10.1097/JCMA.0000000000000295
No abstract available
Publication types
Editorial
Comment
MeSH terms
Animals
Disease Models, Animal
MicroRNAs* / genetics
Myocardial Reperfusion Injury*
Rats
Substances
MIRN25 microRNA, rat
MicroRNAs